Related Experiment Video
Updated: Jun 26, 2026
08:04
Pancreatic Tissue Dissection to Isolate Viable Single Cells
Published on: May 26, 2023
Simulation-based analyses reveal stable microsatellite sequences in human pancreatic cancer
Kei Fujii1, Kaname Miyashita, Yu Yamada
1Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Cancer Genetics and Cytogenetics
|January 27, 2009
Summary
Microsatellite instability (MSI) is rare in pancreatic cancer, contrary to some reports. Our findings suggest microsatellite sequence alterations are not detectable in this malignancy using current methods.
Area of Science:
- Cancer Genetics
- Genomic Analysis
- Tumorigenesis
Background:
- Genomic analysis of tissue samples is crucial in cancer genetics but faces technical limitations.
- Microsatellite instability (MSI) is common in human tumors, but assay frequencies vary significantly across malignancies.
- Pancreatic cancer exhibits conflicting reports regarding MSI prevalence.
Purpose of the Study:
- To investigate the actual frequency of microsatellite instability (MSI) in pancreatic cancer.
- To address discrepancies in reported MSI frequencies for pancreatic cancer.
- To evaluate the suitability of conventional MSI assays and laser-capture microdissection (LCM) for pancreatic cancer analysis.
Main Methods:
- Utilized a unique fluorescent technique for MSI detection in pancreatic cancer tissues.
- Conducted simulations to assess assay sensitivity and cell scarcity effects on MSI detection.
- Analyzed laser-capture microdissection (LCM)-processed cell populations of a microsatellite-unstable colorectal cancer cell line (HCT116).
Main Results:
- Found microsatellite instability (MSI) to be extremely infrequent in pancreatic cancer.
- Demonstrated that low detected frequencies were not due to assay insensitivity or low cancer cell numbers.
- Showed MSI detection in HCT116 cells requires independent growth of two cell populations to a sufficient size, indicating LCM is not advisable when MSI is not detected in tissue samples.
Conclusions:
- Microsatellite sequence alterations are not detectable in human pancreatic cancer.
- Conventional MSI assays and LCM present challenges for accurate detection in certain cancers like pancreatic cancer.
- Further research into novel methodologies may be required for detecting subtle genomic alterations in specific tumor types.
